Siglec9 + tumor-associated macrophages predict prognosis and therapeutic vulnerability in patients with colon cancer.
Chang J, Feng Q, Mao Y, Zhang Z, Xu Y, Chen Y, Zheng P, Lin S, Shen F, Zhang Z, Zhang Z, He G, Xu J, Wei Y.
Chang J, et al. Among authors: wei y.
Int Immunopharmacol. 2024 Mar 30;130:111771. doi: 10.1016/j.intimp.2024.111771. Epub 2024 Mar 2.
Int Immunopharmacol. 2024.
PMID: 38430807
Free article.